3Jakobsson P,Jorfeldt L,von-Schenck H.Fat metabolism and its response to infusion of insulin and glucose in patients with advanced chronic obstructive pulmonary disease[J].Clin Physiol,1995,15(4):319-329.
4Jakobsson P,Jorfeldt L,von-Schenck H.Insulin resistance is not exhibited by advanced chronic obstructive pulmonary disease patients[J].Clin Physiol,1995,15 (6):547-555.
5Rabe KF, Hurd S, Anzueto A. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Cold Executive Summary[J] .Am J Respir Crit Med,2007,176(5) :532-555.
6Stranders I; Diamant M, van Gelder RE, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus[ J]. Arch Inera Med,2004, 164(9) :982 - 988.
7Bochicchio GV, Salzano L,Joshi M, et al. Admission preoperative glucose is predictive of morbidity and mortality in trauma patients who require im- mediate operative intervention[ J]. Am Surg,2005,71(2) : 171-174.
8Christiansen C, Toil P, Jorgensen HS, et al. Hyperglycemia and mortality in critically ill patients. A prospective study[ J]. Intensive Care Med, 2004,30 (8) : 1685-1688.
9Van den Berghe G, Wouters P, Weckers E, etal. Intensive insulin therapy in critically ill patients[J]. New Eng J Med,2001,345(19) : 1359-1367.
10Weston C, Walker L, Birkhead J, et al. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who prosent with an acute coronary syndrome[J]. Heart,2007,93(12) : 1542 -1546.
